Treats clinically important hypotension resulting primarily from vasodilation in the…. ANDA 218412, held by Hainan Poly. Phenylephrine Hydrochloride.
As of Nov 16, 2026, ANDA 218412 (Phenylephrine Hydrochloride), held by Hainan Poly, was first approved by FDA on Mar 14, 2024, with 0 approved supplements and 0 published complete response letters.
Phenylephrine hydrochloride injection is indicated for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 14, 2024 | Original application | Approved | None posted |
| Phenylephrine Hydrochloride10MG/ML (10MG/ML) · solution;intravenous | Phenylephrine Hydrochloride | Rx |
| Phenylephrine Hydrochloride50MG/5ML (10MG/ML) · solution;intravenous | Phenylephrine Hydrochloride | Rx |
| Phenylephrine Hydrochloride100MG/10ML (10MG/ML) · solution;intravenous | Phenylephrine Hydrochloride | Rx |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters